GlassScriptPhysician profile
Steven C Hirsch
NPI 1891738886
$46,155.24
in general payments reported to CMS, 2019-2025
24 companies · $13.61 in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $14K · 2020: $7,600 · 2021: $9,039 · 2022: $5,909 · 2023: $10K · 2024: $20.93 · 2025: $13.61.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $9,568 · Food and Beverage: $501.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $9,567.50 |
| Food and Beverage | $501.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $43,666.84 | 2019-2023 | Repatha |
| E.R. Squibb & Sons, L.L.C. | $604.73 | 2019-2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $295.07 | 2019-2021 | |
| Cardinal Health 200 LLC | $197.56 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $197.45 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $167.69 | 2019-2024 | Wainua |
| Amarin Pharma, INC. | $152.90 | 2019-2020 | |
| Astellas Pharma US INC | $142.77 | 2019 | |
| Impulse Dynamics (USA) INC. | $107.18 | 2023 | Optimizer |
| Pfizer INC. | $94.22 | 2019-2020 | |
| Abiomed | $80.34 | 2019-2022 | |
| Abbott Laboratories | $73.22 | 2019-2020 | |
| Portola Pharmaceuticals, LLC | $72.43 | 2019 | |
| Sanofi-Aventis U.S. LLC | $71.49 | 2019 | |
| Novartis Pharmaceuticals Corporation | $40.99 | 2019 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lundbeck LLC | $39.95 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $30.96 | 2019 | |
| Actelion Pharmaceuticals US, INC. | $25.46 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $25.20 | 2019-2020 | |
| Medtronic Vascular, INC. | $16.78 | 2019 | |
| Philips North America LLC | $14.98 | 2020 | |
| Ionis Pharmaceuticals, INC. | $13.61 | 2025 | Dawnzera |
| Regeneron Healthcare Solutions, INC. | $12.20 | 2019 | |
| Z-Medica, LLC | $11.22 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Hirsch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.